In a statement quoted by Reuters, the company emphasized that trial data do not support a connection and that the benefitrisk profile of semaglutide remains favorable. Still, Novo Nordisk has agreed to update product information in the EU in line with the EMAs recommendation
Despite significant progress observed in clinical trial development, there remains a scarcity of published clinical data, particularly regarding long-term safety, efficacy across diverse populations, and real-world effectiveness
As for Ozempic, you'll inject 0.25 mg weekly for the first four weeks and increase the dose to 0.5 mg afterward
Guidelines for Monitoring Here are some guidelines to help you monitor your heart rate effectively: Check Regularly: Try to check your heart rate at the same time each day
I would love to hear about a medicine like Ozempic being an adjunctive to that conversation, not the center of that conversation, he said